//First large-scale US COVID-19 vaccine trial reaches target enrollment of 30,000 participants

First large-scale US COVID-19 vaccine trial reaches target enrollment of 30,000 participants

Related video above: Coronavirus vaccine timeline impacts everyday life, officials sayModerna, the first company to start U.S. clinical trials of a COVID-19 vaccine, on Thursday finished enrolling all 30,000 of its participants.All 30,000 have received their first shot, and most of them have also received the required second shot.The company’s president says it’s now on track to apply to the Food and Drug Administration for